About
DeepSight Technology is a medical imaging company founded in 2019, based in the San Francisco Bay Area and Clayton, Missouri. The company aims to enhance diagnostic medical ultrasound by providing a platform that is safer, faster, more affordable, and more accessible than traditional imaging methods. Their mission is to redefine image-guided care and improve clinical outcomes. The core offering is a proprietary ultrasound platform that enhances clinical accuracy across various medical applications. This technology expands ultrasound capabilities, enabling advancements in procedures such as biopsies, tumor ablation, and minimally invasive surgery. Key products include the NeedleVue™ LC1 Ultrasound System, which is designed for ultrasound-guided interventional procedures and has received FDA 510(k) clearance. DeepSight Technology utilizes advanced sensing technologies and software tools to innovate in medical diagnostics. The team brings expertise in AI, machine vision, and embedded systems, with a strong foundation in intelligent imaging technologies. The company actively engages with the medical community through participation in major conferences, fostering collaboration with clinicians and researchers.
Technologies
Keywords
Company Information
-
Employees 61
-
Founded 2019
-
Annual Revenue $3200000
-
Total Funding $25000000
Location
Santa Clara, California, United States